Trough-to-peak versus surface ratio in the assessment of antihypertensive agents

Blood Pressure

Volumn 4, Issue 6, 1995, Pages 350-357

  Bieniaszewski, Leszek ^a   Staessen, Jan A ^a   Byttebier, Geert ^a   Leeuw, Peter De ^a   Hedent, Thierry Van ^a   Fagard, Robert ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Ambulatory monitoring; Antihypertensive treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT; LISINOPRIL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME;

EID: 0029557631     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059509077620     Document Type: Article

References (32)

1. Some problems with antihypertensive drug studies in the context of the new guidelines
2. FDA Guidelines on trough: peak ratios in the evaluation of antihypertensive agents
3. Trough/peak ratios for antihypertensive agents. The issue in perspective
4. A randomized comparison of isradipine slow release given once daily withisrapidine twice daily on 24 hour blood pressure in hypertensive patients
5. Effectiveness of once-daily monotherapy with a new nifedipine sustained release calcium antagonist
6. 24-hour efficacy of once-daily diltiazem in essential hypertension
7. Clinical pharmacology of long-acting calcium antagonists: what relevance for therapeutic effects
8. Fosinopril monotherapy: relationship between blood pressure reduction and time of administration
9. for the Italian Nifedipine GITS Study Group. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring
10. Antihypertensive effects of nifedipine GITS on clinic and ambulatory blood pressures in essential hypertensives
11. Methodological considerations in calculation of the trough: peak ratio
12. on behalf of the Advisory Board. APTH–A trial on ambulatory blood pressure monitoring and the treatment of hypertension: objectives and protocol
13. Accuracy of the Space Labs 90207 determined by the British Hypertension Society Protocol
14. Reference values for the ambulatory blood pressure and the blood pressure measured at home: a population study
15. The diurnal blood pressure profile. A population study
16. Ambulatory blood pressure monitoring in elderly patients with isolated systolic hypertension
17. Analysis of the diurnal blood pressure curve
18. An analysis of variance test for normality (complete samples)
19. Statistical methods for assessing agreement between two methods of clinical measurement
20. Trough: peak ratio and twenty-four-hour blood pressure control
21. Trough: peak ratio: the rationale behind the United States Food and Drug Administration recommendations
22. Timing of blood pressure measurements in determining anamalies in duration of effect of an antihypertensive drug: assessment of isradipine
23. Self-measurement of blood pressure at home to evaluate drug effects by the trough: peak ratio
24. on behalf of the Syst-Eur Investigators. Clinical trials with ambulatory blood pressure monitoring: fewer patients needed
25. Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives protocol and organisation
26. Twenty-four hour blood pressure monitoring in the Syst-Eur trial
27. The clinical pharmacology of lisinopril
28. Pharmacokinetics of lisinopril
29. Enalapril maleate and lysine analogue (MK-521): disposition in man
30. Comparison in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE)
31. Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory pressures
32. The ambulatory blood pressure decreases on long-term placebo in older patients with-isolated systolic hypertension